Sustained virologic response of 100% in HCV genotype 1b patients with cirrhosis receiving ombitasvir/paritaprevir/r and dasabuvir for 12weeks - Feld, J J; Moreno, C; Trinh, R (J Hepatol, 2015)
et al.